about
Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayType I interferonopathies in pediatric rheumatologyDendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic ToolsTherapeutic advances in the treatment of vasculitisType I/II cytokines, JAKs, and new strategies for treating autoimmune diseasesSTING: infection, inflammation and cancerInterstitial Lung Disease in Childhood: Clinical and Genetic AspectsAn unexpected role for RNA-sensing toll-like receptors in a murine model of DNA accrualTo Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory TherapiesIdentification of Candidate Predictors of Lupus FlareThe Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor MicroenvironmentNewly recognized Mendelian disorders with rheumatic manifestationsThe STING pathway and the T cell-inflamed tumor microenvironmentLung Involvement in Children with Hereditary Autoinflammatory DisordersMolecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of CancerInnate immune recognition of DNA: A recent historyNucleic Acid-Sensing Receptors: Rheostats of Autoimmunity and AutoinflammationAdvances in lupus geneticsHuman USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome.Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive SurveyCrosstalk Between Apoptosis and Autophagy: Environmental Genotoxins, Infection, and Innate Immunity.USP13 negatively regulates antiviral responses by deubiquitinating STINGWhen less is more: primary immunodeficiency with an autoinflammatory kickTargeting of type I interferon in systemic autoimmune diseasesAicardi-Goutières syndrome and the type I interferonopathies.Severe Early-Onset Combined Immunodeficiency due to Heterozygous Gain-of-Function Mutations in STAT1STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells.Cutting edge: AIM2 and endosomal TLRs differentially regulate arthritis and autoantibody production in DNase II-deficient miceSuppression of systemic autoimmunity by the innate immune adaptor STING.Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestationsImmunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kindDefective removal of ribonucleotides from DNA promotes systemic autoimmunity.OASes and STING: adaptive evolution in concertSingle amino acid change in STING leads to constitutive active signaling.The Broad-Spectrum Antiviral Protein ZAP Restricts Human RetrotranspositionLinking classification and therapeutic management of vasculitides.Animal Models of Interferon Signature Positive Lupus.Somatic NOD2 mosaicism in Blau syndromeSTING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease.New monogenic autoinflammatory diseases--a clinical overview
P2860
Q26746697-3DC74CF4-03B9-4C28-8F0B-966603A59664Q26748746-210F81A4-3AAC-4BC1-8611-D912085F1917Q26749296-96E958C5-DCF8-40F9-870E-D7A00879286BQ26750499-73BD415B-3C8B-447A-A435-BCF494688F07Q26775111-CF30FDFB-AD6A-4512-9DE6-BBD06C621D15Q26776009-1B90749F-8E7E-45BD-84E3-A1A67A04ED65Q26778109-3776CC10-43CC-4B10-A488-22D347C31046Q26784225-D1B6F5FF-33AB-4535-B68A-EC8C350E4089Q26786973-D3338425-E1CD-4719-ABF2-A85FA065BBBFQ26795372-ACE24B2D-1887-4069-8E6E-3BE23563AC2CQ26796305-C6203805-1134-4136-974B-E5EA16D2426BQ26996730-6C4705F8-2DC0-4F98-8A90-50085B6981EDQ27008371-B3F2E3D5-AFB8-41DC-8B7D-8803AEC2E610Q28071911-2CC768E8-0CF5-4AD1-8817-77E5648850D1Q28080773-27395965-D7E5-4AA3-9E8D-CBF413195908Q28080982-39C47FDA-CBA6-4BBB-86EE-E097B0AB03A0Q28081728-0705E559-4E83-48C6-ABE7-A51B7840424AQ28088718-078A8204-EEC4-42D9-9FF2-C22877767E09Q30090228-6015A7F0-73D2-47CA-951C-6086164F65B9Q33430541-032F404F-8FA3-4F23-9751-A064840A7551Q33565957-3E3A1ADE-75F0-475C-A78C-B4A9D12B7BD9Q33759160-CFC20254-5D14-4E8E-A45A-4FA79DDF1F07Q34420031-76138F8F-0CE6-4CCF-A5B7-325082E13487Q34451758-4F453909-9F7E-4159-AE1E-99CA0F85B5B0Q34479620-B2AA5500-6515-4217-B9AF-363142D4B270Q34532987-61FD7361-2C77-4476-BEE6-A5667DF0E745Q34646599-2A868A4C-518E-486D-9AE2-14CAF412B76FQ34987413-F559106D-7132-434C-B05F-7DCCB5716968Q35128992-24EBB10B-A4F9-4C18-B651-282637F02CA0Q35145346-3649CF55-9CE7-4869-A31D-589FC097EE91Q35190461-96F3F4D6-1E24-4B09-8A77-25B2DA9312B7Q35242453-4D7F13BE-B133-4834-AAAF-5619E707D4FEQ35569805-83032015-764A-40B3-AD09-6F7FBCA1F8A0Q35581615-4826B08F-0549-47E4-A8C0-DB542DC82CC2Q35639494-DEA5F175-573B-40B4-93C6-7C2A963681EEQ35672892-AEE94366-7E40-4594-8194-BBA23D500A25Q35686914-84A63D62-C12D-4BCF-9326-88077AECAD66Q35931519-7C9D03CF-C449-4383-913E-C4CF20AD7912Q35956285-3469E0B4-1F4B-449B-B6CB-648310188D87Q36016335-E4564E8E-2051-4672-9B3E-96A05C10D3A1
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Activated STING in a vascular and pulmonary syndrome
@ast
Activated STING in a vascular and pulmonary syndrome
@en
Activated STING in a vascular and pulmonary syndrome
@nl
type
label
Activated STING in a vascular and pulmonary syndrome
@ast
Activated STING in a vascular and pulmonary syndrome
@en
Activated STING in a vascular and pulmonary syndrome
@nl
prefLabel
Activated STING in a vascular and pulmonary syndrome
@ast
Activated STING in a vascular and pulmonary syndrome
@en
Activated STING in a vascular and pulmonary syndrome
@nl
P2093
P2860
P50
P356
P1476
Activated STING in a vascular and pulmonary syndrome
@en
P2093
A Barysenka
A Biancotto
A C Issekutz
A C Steven
B Gonzalez
C P Minniti
C St Hilaire
D Chapelle
P2860
P304
P356
10.1056/NEJMOA1312625
P407
P577
2014-07-16T00:00:00Z